BSI Life Sciences, an industry leader in CTMS and eTMF software solutions, announces a new integrated partnership with Marvin EDC, bringing together the complementary technologies of both companies to support the latest clinical developments.
The partnership enables seamless data exchange between BSI Life Sciences’ clinical operations platform and AB Cube’s Marvin EDC, providing sponsors and CROs with a connected and compliant environment without sacrificing flexibility or the ability to work with their preferred tools.
“Marvin and BSI Life Sciences’ eClinical solutions are built on the same commitment to interoperability, open standards, and strong ease of use. For clinical leaders, this means less integration effort, fewer duplicate inputs, and a more reliable flow of information from data capture to operational management and TMF documentation.”said Philip Sku, Managing Director of BSI Life Sciences.
By connecting Marvin to BSI Life Sciences’ CTMS and eTMF, we are integrating complementary technologies for the latest clinical development. This partnership supports best-of-breed strategies while providing sponsors and CROs with a connected and compliant platform across clinical data, operations, pharmacovigilance, and trial documentation. ”
Manuel Neukam, AB Cube Germany GmbH CEO
This integration reflects growing demand from research teams for interoperable solutions that reduce manual data reconciliation and simplify workflows between systems while maintaining the compliance standards required for regulated clinical research.
